MedTrace Logo

Immune Responses After Human Subject Challenge With Sand Fly Bites

NCT01289977 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68

Last updated 2018-02-19

No results posted yet for this study

Summary

Sand flies can carry the infection leishmaniasis (a parasite). The purpose of this study is to evaluate the human immune response to uninfected laboratory raised sand fly bites and select from the immune response to sand fly saliva, possible substances to use for a future vaccine to protect against the parasite leishmaniasis.

Conditions

  • Healthy

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Uniformed Services University of the Health Sciences

    lead FED

Principal Investigators

  • Naomi E Aronson, MD · Uniformed Services University of the Health Sciences

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2016-04-30
Completion
2016-04-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01289977 on ClinicalTrials.gov